Chemotherapy Induced Systolic Dysfunction

1

Review clinical trials related to Chemotherapy Induced Systolic Dysfunction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Fibrosis in Chronic and Delayed Myocardial Infarction

In this study the investigators aim to examine the role that fibrosis plays in heart conditions such as aortic stenosis , chemotherapy-induced cardiotoxicity and carcinoid syndrome . Fibrosis is a common final result following any injury to the heart muscle and the investigators aim to identify this process early and in its active state. This will be examined by using a radiotracer 68Ga-FAPI or 18F-AlF-FAPI and PET-MRI or PET-CT.

Participants needed: 180
Trial details
Age: 40-90Biological sex: AllType: ObservationalSponsor: University of EdinburghUpdated: Jan 9, 2026Locations: 1
Eligibility criteria

Male or female above the age of 50 years old [+12]

Inability or unwilling to give informed consent. [+6]